Back to search

Article

Assessing <i>Corynebacterium glutamicum</i> as a surrogate of <i>Mycobacterium tuberculosis</i> for DNA gyrase inhibitor design

2026-06-24

Abstract excerpt

<h4>ABSTRACT</h4> DNA gyrase is an essential bacterial enzyme and a clinically validated target for the treatment of tuberculosis. However, the discovery of new inhibitors remains limited by the many challenges regarding the manipulation on pathogenic mycobacteria. This study validates Corynebacterium glutamicum ( Cglu ) as a safe, non-pathogenic surrogate for Mycobacterium tuberculosis ( Mtb ) to investigate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f13f7e1f-d5e1-5934-b8d5-221ed7bdc38c
DOI
10.64898/2026.06.24.734172
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Assessing <i>Corynebacterium glutamicum</i> as a surrogate of <i>Mycobacterium tuberculosis</i> for DNA gyrase inhibitor designDOI 10.64898/2026.06.24.734172
Select a neighboring publication to make it the new centre.